Yven Van Herrewege

In Vitro Evaluation of Nonnucleoside Reverse Transcriptase Inhibitors UC-781 and TMC120-R147681 as Human Immunodeficiency Virus Microbicides

Yven Van Herrewege, Jo Michiels, Jens Van Roey et al. · Antimicrobial Agents and Chemotherapy · 2003 · 137 citations · Full text

T Cells, Medicine, Human Retrovirus +14

Carbohydrate-Binding Agents Efficiently Prevent Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin (DC-SIGN)-Directed HIV-1 Transmission to T Lymphocytes

Jan Balzarini, Yven Van Herrewege, Kurt Vermeire et al. · Molecular Pharmacology · 2006 · 79 citations · Full text

Preexposure Intradermal Rabies Vaccination: A Noninferiority Trial in Healthy Adults on Shortening the Vaccination Schedule From 28 to 7 Days

Patrick Soentjens, Petra Andries, Annelies Aerssens et al. · Clinical Infectious Diseases · 2018 · 56 citations · Full text

A Series of Diaryltriazines and Diarylpyrimidines Are Highly Potent Nonnucleoside Reverse Transcriptase Inhibitors with Possible Applications as Microbicides

Yven Van Herrewege, Guido Vanham, Jo Michiels et al. · Antimicrobial Agents and Chemotherapy · 2004 · 55 citations · Full text

Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial

Christophe Van Dijck, Achilleas Tsoumanis, Anke Rotsaert et al. · The Lancet Infectious Diseases · 2021 · 44 citations

Sexual Health, Preventive Medicine, Crossover Trial +9